Format

Send to

Choose Destination
J Geriatr Psychiatry Neurol. 1992 Apr-Jun;5(2):93-101.

Cytochrome oxidase inhibition: a novel animal model of Alzheimer's disease.

Author information

1
Department of Pharmacology, University of Colorado Health Sciences Center, Denver 80262.

Abstract

A profound decrease in activity of the mitochondrial enzyme cytochrome oxidase in blood platelets is a recently identified concomitant of Alzheimer's disease (AD). We investigated a possible pathogenic link between this finding and the symptoms of AD by mimicking this mitochondrial enzyme deficiency in rats. Rats were infused chronically with a selective inhibitor of cytochrome oxidase, sodium azide, or with saline delivered via subcutaneously implanted osmotic minipumps. The azide treatment impaired both spatial and nonspatial learning. Further, the azide treatment inhibited a low-threshold form of hippocampal long-term potentiation, primed burst potentiation. The behavioral deficits were not secondary to a sensory or motor impairment. Thus, chronic azide treatment of rats models some characteristics of AD.

PMID:
1317179
DOI:
10.1177/002383099200500206
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center